Five-month results from Diamyd® trial in LADA published in peer-reviewed scientific journal

An article presenting the 5-month interim results from the open-label trial GADinLADA that assessed three intralymphatic injections of the therapeutic diabetes vaccine Diamyd[®],[ ]has been published in the peer-reviewed scientific journal Frontiers in Endocrinology.As communicated on December 7, 2021, immunological analyses after 5-months showed that the treatment with Diamyd[®] induced a clear GAD-specific immune response both in term of antibodies and cell-based reactions in individuals diagnosed with LADA . The publication is entitled "Latent Autoimmune Diabetes in Adults: Background,